Serum Institute, Bharat Biotech to speed up Covid-19 vaccine production

This comes after govt panel visits facilities of SII and Bharat Biotech

A visit by a government panel to the facilities of Serum Institute of India (SII) and Bharat Biotech has put both the companies on an overdrive to raise capacities of Covid-19 vaccines, Covishield and Covaxin, respectively.
 
“The manufacturers were asked to come up with ‘innovative’ ways to ramp up capacities quickly as the domestic vaccine demand is on the rise,” said a member of the panel.
 
He added that this may include repurposing existing capacities or forging manufacturing tie-ups.
 
Both the vaccine makers had sought funds from the government to ramp up production.
 
Sources said SII